Tassos Georgiadis PhD

Tassos Georgiadis, PhD, has served as our Vice President of Preclinical Development. Dr Georgiadis has been researching virus-mediated gene therapy for over 18 years, specialising in AAV gene therapy vector design and neurodegeneration. Before joining MeiraGTx, Dr Georgiadis worked at the UCL Institute of Child Health and the UCL Institute of Ophthalmology, where he focused on ocular disorders and regulation of gene expression. Dr Georgiadis currently sits on the UK Health Research Authority Research Ethics Committee as an Expert Member. He also served as an elected member of the Board of the British Society for Gene and Cell Therapy, as well as a scientific consultant for Athena Vision, a biotechnology company. Dr Georgiadis has a BSc in Genetics from Queen Mary & Westfield College, an MSc in Human Molecular Genetics from Imperial College, University of London, and a PhD in Molecular Genetics from University College London.